Biotech

All Articles

Relay loses interest in SHP2 prevention after Genentech leaves

.Three weeks after Roche's Genentech unit bowed out an SHP2 inhibitor contract, Relay Rehab has affi...

Stoke's Dravet disorder med discharged of predisposed scientific grip

.Stoke Therapeutics' Dravet syndrome medicine has been freed from a partial grip, getting rid of the...

Fierce Biotech's Gabrielle Masson provides Fierce 15 at NYSE

.Strong Biotech Associate Publisher Gabrielle Masson offered the 2024 training class of Tough 15 win...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has actually axed its own once-monthly twin GLP-1/ GIP receptor agonist, ending (PDF) ...

Daiichi pays Merck $170M to create bronchi cancer T-cell engager treaty

.Merck &amp Co. has rapidly made back a number of the costs of its own Harp on Therapeutics acquisti...

BioMarin standstills preclinical gene treatment for heart disease

.After BioMarin administered a springtime clean of its pipe in April, the business has actually dete...

Eisai plants molecular adhesive SEED along with $1.5 B biobucks deal

.Major Pharmas continue to be caught to the idea of molecular glue degraders. The most recent busine...

Life scientific research credit organization reveals with $600M

.A brand-new international life science credit report firm, nicknamed Symbiotic Capital, has actuall...

BMS ditches TIGIT, leaving $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing an additional big wager from the Caforio era, terminating an...

Nuvation standstills BET inhibitor after taking into consideration phase 1 data

.After looking at period 1 data, Nuvation Bio has actually made a decision to halt focus on its one-...